DRKS00029311
Completed
Not Applicable
Medical evaluation of care and re-evaluation of the success of the therapy of the halitosis consultation
Departement of operative dentistry0 sites60 target enrollmentJanuary 4, 2023
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- R19.6
- Sponsor
- Departement of operative dentistry
- Enrollment
- 60
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Participation halitosis consultation
Exclusion Criteria
- •No Participation halitosis consultation
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
utritional Assessment and Health Status of Dialysis patientsHealth Condition 1: null- dialysisCTRI/2015/06/005924Bahar Z Mukri100
Not yet recruiting
Not Applicable
Clinical evaluation In the health outcome of patients with bronchial asthma at the first visit and unscheduled visit with budesonide/formoterol therapybronchial asthmaJPRN-UMIN000028486Hiroshima Allergy and Pulmonary Clinic30
Completed
Not Applicable
Trial of a primary health care mobile health system for identification and management of Common Mental Disorders in rural Andhra PradeshHealth Condition 1: null- Mental HealthCTRI/2017/10/009992Grand Challenges Canada5,167
Recruiting
Not Applicable
The Systematic Medical Appraisal, Referral and Treatment (SMART) Mental Health ProgrammeHealth Condition 1: null- Mental HealthHealth Condition 2: F068- Other specified mental disorders due to known physiological conditionCTRI/2018/08/015355The George Institute For Global Health
Completed
Not Applicable
Study to evaluate health care situation and quality of life in patients with registered anti-VEGF treatment in neovascular AMD, diabetic macular edema or retinal vein occlusioPatients with neovascular AMD or visual impairment due to diabetic macular edema or visual impairment due to retinal vein occlusion.H34.8H35.3H35.8Other retinal vascular occlusionsDegeneration of macula and posterior poleOther specified retinal disordersDRKS00010267ovartis Pharma GmbH3,224